Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size
- 31 July 2008
- journal article
- Published by Elsevier BV in Journal of Molecular and Cellular Cardiology
- Vol. 45 (1), 106-117
- https://doi.org/10.1016/j.yjmcc.2008.03.022
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL59225, HL63760)
- University of Louisville
This publication has 29 references indexed in Scilit:
- Cardiac growth and angiogenesis coordinated by intertissue interactionsJCI Insight, 2007
- Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in miceThe Journal of Experimental Medicine, 2007
- Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophyProceedings of the National Academy of Sciences of the United States of America, 2006
- Vascular Endothelial Growth Factor Prevents Apoptosis and Preserves Contractile Function in Hypertrophied Infant HeartCirculation, 2006
- Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure OverloadHypertension, 2006
- Heart failure improvement from a supplement containing copperEuropean Heart Journal, 2005
- The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failureEuropean Heart Journal, 2005
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failureJCI Insight, 2005
- Inhibition of phenylephrine‐induced cardiac hypertrophy by docosahexaenoic acidJournal of Cellular Biochemistry, 2004